Found: 29
Select item for more details and to access through your institution.
MERS-CoV?Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination.
- Published in:
- Emerging Infectious Diseases, 2023, v. 29, n. 6, p. 1236, doi. 10.3201/eid2906.220128
- By:
- Publication type:
- Article
Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement Home.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Immunogenic cell death of dendritic cells following modified vaccinia virus Ankara infection enhances CD8<sup>+</sup> T cell proliferation.
- Published in:
- European Journal of Immunology, 2018, v. 48, n. 12, p. 2042, doi. 10.1002/eji.201847632
- By:
- Publication type:
- Article
Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36907-0
- By:
- Publication type:
- Article
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31557-0
- By:
- Publication type:
- Article
Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 52, doi. 10.3390/vaccines12010052
- By:
- Publication type:
- Article
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040533
- By:
- Publication type:
- Article
Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 451, doi. 10.3390/vaccines8030451
- By:
- Publication type:
- Article
Multi‐species ELISA for the detection of antibodies against SARS‐CoV‐2 in animals.
- Published in:
- Transboundary & Emerging Diseases, 2021, v. 68, n. 4, p. 1779, doi. 10.1111/tbed.13926
- By:
- Publication type:
- Article
Generation of therapeutic antisera for emerging viral infections.
- Published in:
- NPJ Vaccines, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41541-018-0082-4
- By:
- Publication type:
- Article
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-023-00801-z
- By:
- Publication type:
- Article
Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice.
- Published in:
- Pathogens, 2023, v. 12, n. 7, p. 867, doi. 10.3390/pathogens12070867
- By:
- Publication type:
- Article
The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2023, p. 1, doi. 10.3389/fcimb.2023.1259822
- By:
- Publication type:
- Article
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 3, p. 417, doi. 10.3390/v16030417
- By:
- Publication type:
- Article
Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 5, p. 1180, doi. 10.3390/v15051180
- By:
- Publication type:
- Article
An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus Inoculation.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/v14071401
- By:
- Publication type:
- Article
Obstetric Ultrasonography to Detect Fetal Abnormalities in a Mouse Model for Zika Virus Infection.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 1, p. 72, doi. 10.3390/v12010072
- By:
- Publication type:
- Article
A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 1, p. 26, doi. 10.3390/v12010026
- By:
- Publication type:
- Article
CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.
- Published in:
- Viruses (1999-4915), 2018, v. 10, n. 12, p. 718, doi. 10.3390/v10120718
- By:
- Publication type:
- Article
Tracking Modified Vaccinia Virus Ankara in the Chicken Embryo: In Vivo Tropism and Pathogenesis of Egg Infections.
- Published in:
- Viruses (1999-4915), 2018, v. 10, n. 9, p. 452, doi. 10.3390/v10090452
- By:
- Publication type:
- Article
E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
- Published in:
- Viruses (1999-4915), 2018, v. 10, n. 1, p. 21, doi. 10.3390/v10010021
- By:
- Publication type:
- Article
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases.
- Published in:
- Viruses (1999-4915), 2014, v. 6, n. 7, p. 2735, doi. 10.3390/v6072735
- By:
- Publication type:
- Article
SARS-CoV-2 inactivation in laboratory animal tissues with 4% formaldehyde or 5% glutaraldehyde for transfer to biosafety level 1 laboratories.
- Published in:
- Veterinary Pathology, 2024, v. 61, n. 2, p. 201, doi. 10.1177/03009858231197128
- By:
- Publication type:
- Article
Critical Role of Perforin-dependent CD8+ T Cell Immunity for Rapid Protective Vaccination in a Murine Model for Human Smallpox.
- Published in:
- PLoS Pathogens, 2012, v. 8, n. 3, p. 1, doi. 10.1371/journal.ppat.1002557
- By:
- Publication type:
- Article
Editorial on special issue on "Immunobiology of Viral Infections".
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Mouse models in COVID-19 research: analyzing the adaptive immune response.
- Published in:
- Medical Microbiology & Immunology, 2023, v. 212, n. 2, p. 165, doi. 10.1007/s00430-022-00735-8
- By:
- Publication type:
- Article
Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice against Lethal Challenge.
- Published in:
- PLoS Neglected Tropical Diseases, 2014, v. 8, n. 9, p. 1, doi. 10.1371/journal.pntd.0003101
- By:
- Publication type:
- Article
Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice against Lethal Challenge.
- Published in:
- PLoS Neglected Tropical Diseases, 2014, v. 8, n. 9, p. 1, doi. 10.1371/journal.pntd.0003101
- By:
- Publication type:
- Article
Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 20, p. 10898, doi. 10.3390/ijms252010898
- By:
- Publication type:
- Article